Low-acid Contrast Media for Preventing Post ERCP Pancreatitis
NCT07391787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3979
Last updated 2026-02-06
Summary
Title: Low-acid contrast media for preventing post ERCP pancreatitis: a multicenter, retrospective, cohort study (LAMP-R) .
Objective:
Main objective: This study aims to determine whether low-acid contrast media can reduce the incidence of post-ERCP pancreatitis.
Secondary objective: To investigate the severity of post-ERCP pancreatitis, the incidence rate of other complications, and the risk factors associated with different pH values of contrast media.
Research Design:Multicenter, retrospective cohort study.
Research participants:
Inclusion criteria: Patients aged 18 to 90 years who underwent ERCP diagnostic and therapeutic procedures were included consecutively.
Exclusion criteria: Patients who did not use contrast medium during ERCP, failed ERCP papillary intubation, developed acute pancreatitis within 3 days before surgery, ERCP stent removal/replacement, had a history of pancreaticoduodenectomy or biliary-enteric anastomosis, and whose postoperative amylase/lipase levels could not be traced were excluded.
Outcomes:
1\. The rate of post-ERCP pancreatitis and severity of PEP 2. The rate of infection 3. The rate of gastrointestinal bleeding 4. The rate of perforation.
Sample size calculation:
A total of approximately 3,881 eligible ERCP patients were included from five tertiary Grade A centers. Specifically, 2,305 patients were from Qilu Hospital of Shandong University, 463 from Linyi People's Hospital, 121 from Qilu Third Hospital of Shandong University, 106 from Dezhou Hospital of Qilu Hospital of Shandong University, and 886 from Shengli Oilfield Central Hospital.
Statistical analysis SPSS 27 is used for statistics and analysis, including descriptive analysis, single-factor and multi-factor logistic regression analysis, analysis of variance, t-test, propensity score matching (PSM), etc. Categorical data are presented as counts and proportions, while continuous data are presented as mean ± standard deviation, depending on the distribution. Categorical data are analyzed using χ2 and Fisher's exact test, and continuous data are analyzed using Student's t-test or Mann-Whitney U test. Primary and secondary outcomes are presented as relative risks (RRs) with 95% confidence intervals (CIs).
Conditions
- Post-ERCP Acute Pancreatitis
Interventions
- DRUG
-
Ioversol
Ioversol was used for intervention in the ERCP procedure, while iopromide was used for controlled. ERCP was performed using endoscopes from different suppliers, and the guidewire assisted method were used for the papillary intubation.
- DRUG
-
Iopromide
Iopromide was used for ERCP procedure as controlled group. ERCP was performed using endoscopes from different suppliers, and the guidewire assisted method were used for the papillary intubation.
- DRUG
-
Iohexol
Iohexol was used for intervention in the ERCP procedure, while iopromide was used for controlled. ERCP was performed using endoscopes from different suppliers, and the guidewire assisted method were used for the papillary intubation.
Sponsors & Collaborators
-
Shandong University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2025-12-25
- Completion
- 2026-01-15
Countries
- China
Study Locations
More Related Trials
-
COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis
NCT02964403 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
NCT04619511 ·Status: COMPLETED
-
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
NCT03713879 ·Status: RECRUITING ·Phase: PHASE3
-
Tailored Hydration for the Prevention of Post-ERCP Pancreatitis
NCT03561441 ·Status: COMPLETED ·Phase: NA
-
Treatment Strategy of Pancreatic Radiolucent Stone
NCT04628273 ·Status: COMPLETED
-
Effect of Anatomy of Major Duodenal Papilla on the Difficulty of Cannulation During Endoscopic Retrograde Cholangiopancreatography
NCT03550768 ·Status: COMPLETED
-
Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis
NCT07407491 ·Status: RECRUITING ·Phase: PHASE2
-
The Prophylactic Effect of Stilamin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
NCT01431781 ·Status: UNKNOWN ·Phase: NA
-
The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders
NCT00861198 ·Status: COMPLETED
-
ERCP in Idiopathic Recurrent Acute Pancreatitis
NCT01583517 ·Status: COMPLETED ·Phase: NA
-
Infection Control in ERCP Using a Duodenoscope With a Disposable Cap
NCT04040504 ·Status: COMPLETED ·Phase: NA
-
Study of Abdominal Drainage in LCBDE+PC
NCT03120754 ·Status: UNKNOWN ·Phase: NA
-
Non-inferiority of Pharmacological Prevention Alone Versus Pancreatic Stents to Prevent Post-ERCP Pancreatitis
NCT02368795 ·Status: UNKNOWN ·Phase: NA
-
Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis
NCT01912716 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fluorescent Cholangiography and Bile Duct Stones
NCT03530241 ·Status: WITHDRAWN ·Phase: NA
-
Bile Omics for Diagnosing Indeterminate Biliary Strictures
NCT07007832 ·Status: RECRUITING
-
Acute PAncreatitis and Home Care vs. Hospital Admission Study
NCT05360797 ·Status: UNKNOWN ·Phase: NA
-
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
NCT02531607 ·Status: ACTIVE_NOT_RECRUITING
-
Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.
NCT05270434 ·Status: COMPLETED ·Phase: NA
-
Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
NCT02543957 ·Status: WITHDRAWN
-
Incidence and Predictors of Bleeding During and Following ERCP
NCT05929404 ·Status: COMPLETED
-
An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
NCT05267379 ·Status: RECRUITING
-
PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents
NCT05817721 ·Status: COMPLETED
-
Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis
NCT06260878 ·Status: RECRUITING ·Phase: PHASE4
-
ESWL Versus ESWL and Endoscopic Treatment
NCT02971475 ·Status: UNKNOWN ·Phase: NA